Citation Impact
Citing Papers
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Normal gut microbiota modulates brain development and behavior
2011 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Sexual Dysfunction, Depression, and the Impact of Antidepressants
2009
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
2015
Drug treatments in Alzheimer’s disease
2016
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
2021
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
2007
Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents
2007
Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
2020
Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder
2011
Depression
2018 Standout
Augmentation of Antidepressants with Atypical Antipsychotics: A Review of the Current Literature
2008
Major depressive disorder
2016 Standout
Drug development in Alzheimer’s disease: the path to 2025
2016
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
2009
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
2019
Alzheimer disease
2021
Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain
2007
On the path to 2025: understanding the Alzheimer’s disease continuum
2017
Identifying incipient dementia individuals using machine learning and amyloid imaging
2017
Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
2015
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
2018
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Chronic olanzapine activates the Stat3 signal transduction pathway and alters expression of components of the 5-HT2A receptor signaling system in rat frontal cortex
2007
Design of amyloidogenic peptide traps
2024 StandoutNobel
Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression
2009
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
Antidepressant-like effects of N-acetyl-L-cysteine in rats
2008
Alzheimer Disease
2017
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
The road to restoring neural circuits for the treatment of Alzheimer's disease
2016 Nature
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses
2016 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Current and Future Treatments in Alzheimer Disease: An Update
2020
Lecanemab in Early Alzheimer’s Disease
2022 Standout
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
2017
Picosecond large-signal switching characteristics of a pseudomorphic AlGaAs/InGaAs modulated doped field effect transistor
1992 StandoutNobel
Determining clinically meaningful decline in preclinical Alzheimer disease
2019
Prevalence and management of treatment-resistant depression.
2007
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia
2019
GaAs nonlinear transmission lines for picosecond pulse generation and millimeter-wave sampling
1991
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
2018
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
2015
Donanemab in Early Alzheimer’s Disease
2021
The unfolded protein response in neurodegenerative disorders – therapeutic modulation of the PERK pathway
2018
Works of Michael Case being referenced
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression
2006
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder
2007
Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression
2007
Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia
2015
Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression
2005
Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression
2012
Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia
2018
Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's disease
2019
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
2015
Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia
2013
[O5–01–01]: PET BIOMARKERS IN THE EXPEDITION 3 TRIAL OF PATIENTS WITH MILD AD
2017
Statistical properties of continuous composite scales and implications for drug development
2017
Impulse compression using soliton effects in a monolithic GaAs circuit
1991